glp 1 discontinuation rates Getting off Wegovy/Zepbound Weight Loss Medication Weight maintenance after discontinuation of

doi: 10.1016/j.cmet.2012.06.015 31 AlhadeffALBairdJ-PSwickJCHayesMRGrillHJ

Herman G., Stevens C., Vandyck K., et al., Pharmacokinetics and Pharmacodynamics of Sitagliptin, an Inhibitor of Dipeptidyl Peptidase IV, in Healthy Subjects: Results From Two Randomized, DoubleBlind, PlaceboControlled Studies With Single Oral Doses, Clinical Pharmacology and Therapeutics 78, no

Key Takeaways BioCare shows up for GLP-1 patients beyond the product

Proper storage ensures medication efficacy and reduces waste

E., Sogin M

"With Foundayo, we now have an oral option that delivered an average of 12.4% weight loss at the highest dose in clinical trials addressing both the clinical realities of obesity and the practical challenges patients face every day." Supported by the ATTAIN clinical trial programme, Foundayo was proven to help people lose weight and keep it off